EFFECT OF DAILY LOW-DOSE MIFEPRISTONE ON THE OVARIAN CYCLE AND ON DYNAMICS OF FOLLICLE GROWTH

被引：27

作者：

CAMERON, ST ^{[1
]}

THONG, KJ ^{[1
]}

BAIRD, DT ^{[1
]}

机构：

[1] UNIV EDINBURGH, CTR REPROD BIOL, DEPT OBSTET & GYNAECOL, EDINBURGH EH3 9EW, MIDLOTHIAN, SCOTLAND

来源：

CLINICAL ENDOCRINOLOGY | 1995年 / 43卷 / 04期

关键词：

D O I：

10.1111/j.1365-2265.1995.tb02610.x

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

BACKGROUND AND OBJECTIVE The antiprogestin mifepristone has been shown to disrupt folliculogenesis and endometrial maturation and, therefore, has the potential to be used as a novel form of contraception. The purpose of this study was to investigate further the effects of daily administration of a low dose of mifepristone (2mg) on the ovarian cycle and on the dynamics of follicle growth. SUBJECTS Six healthy female volunteers were given 2mg mifepristone daily for 30 days following an ovulatory control cycle. MEASUREMENTS Follicle growth was monitored with transvaginal ultrasonography and hormonal measurements in blood and urine were used to monitor effects on the ovarian cycle. In addition, concentrations of cortisol and ACTH in serum were measured to assess the effects of mifepristone on the pituitary-adrenal axis. RESULTS Treatment with mifepristone retarded the follicular growth rate in all women (P = 0.01). Ovulation was inhibited in 4 of 6 subjects and appeared to be mediated through an effect on the hypothalamo-pituitary axis, as no surge of FSH or LH occurred. In these subjects the dominant follicle continued to grow and developed into a persistent follicle. In two cases the persistent follicle remained functional and ovulation occurred soon after stopping treatment. In the remaining two subjects, the dominant follicle developed into a non-functioning cyst (>30mm) which persisted for one month after the end of the post-treatment cycle. In the two subjects who ovulated, the LH surge was delayed by 6 and 7 days but was followed by a luteal phase of normal length. There was no significant change in the concentration of ACTH or cortisol suggesting that treatment with mifepristone in this dose has little if any effect on the pituitary-adrenal axis. CONCLUSION These findings add further evidence to support the contraceptive potential of mifepristone through effects on follicular development and on the menstrual cycle.

引用

页码：407 / 414

页数：8

共 23 条

[1]

Baird D.T., Potential contraceptive effects of antigestogens, in: Clinical Applications of Mifepristone RU 486 and Other Antiprogestins, pp. 148-162, (1993)

[2]

Baird D.T., Thong K.J., Hall C., Cameron S.T., Failure of oestrogen induced LH surge in women treated with mifepristone every day for 30 days, (1995)

[3]

Batista M.C., Cartledge T.P., Zellmer W., Nieman L.K., Merriam G.R., Loriaux D.L., Evidence for a critical role of progesterone in the regulation of the mid cycle gonadotropin surge and ovulation, Journal of Clinical Endocrinology and Metabolism, 74, pp. 565-570, (1992)

[4]

Baulieu E.-E., An antiprogestin steroid with contragestive activity in women, in: The Antiprogestin Steroid RU 486 and Human Fertility Control, pp. 1-26, (1986)

[5]

Bertagna X., Bertagna C., Luton J.P., Husson J.M., Girard F., The new steroid analogue RU 486 inhibits glucocorticoid action in man, Journal of Clinical Endocrinology and Metabolism, 59, pp. 25-28, (1984)

[6]

Cameron S.T., Critchley H.O.D., Thong K.J., Buckley C.H., Baird D.T., Effects of continuous low dose mifepristone on the endometrium, Journal of Reproduction and Fertility, 14, (1994)

[7]

Croxatto H.B., Salvatierra A.M., Croxatto H.D., Fuentealba V., Effects of continuous treatment with low dose mifepristone throughout one menstrual cycle, Human Reproduction, 8, pp. 201-207, (1993)

[8]

Croxatto H.B., Salvatierra A.M., Fuentealba B., Zurth C., Beier S., Effect of the antiprogestin onapristone on follicular growth in women, Human Reproduction, 9, pp. 1442-1447, (1994)

[9]

Garzo V.G., Liu J., Ulmann A., Baulieu E., Yen S.S.C., Effects of an antiprogesterone (RH 486) on the hypothalamichypophyseal ovarian‐endometrial axis during the luteal phase of the menstrual cycle, Journal of Clinical Endocrinology and Metabolism, 66, pp. 508-517, (1988)

[10]

Kekkonen R., Lahteenmaki P., Luukkainen R., Tuominen J., Sequential regimen of the antiprogesterone RU 486 and synthetic progestin for contraception, Fertility and Sterility, 60, pp. 610-615, (1993)

← 1 2 3 →